Evaluation of botox treatment for patients with primary axillary hyperhidrosis in Basrah

Abstract EN

Hyperhidrosis is a distressing condition that affects the social life of many patients.

Botox has been discovered to treat this problem.

This study aimed to evaluate the response of the patients to Botulinum toxin type A (BTX-A) and the time interval between injections during which the patient is free from symptoms.

The study evaluates subjectively the response of patients with axillary hyperhidrosis to Botox with 100 % scale and Hyperhidrosis Disease Severity Scale (HDSS).

The time interval between injections was also evaluated.

The data were collected prospectively and analyzed.

This study included 21 patients with mean age of 27 years.

Twenty of them were males.

Of the 21 patients, 33 % were subjected to multiple sessions.

The response in 18 (85 %) of patients was between 90-100 %.

The average time interval between injections was 211 days.

In conclusion, botulinum toxin type A (BTX-A) has significant benefit in treating patient with axillary hyperhidrosis with rapid onset and the average duration of symptom free period was 7 months.